Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -125,205 | -102,978 | -37,783 | 19,675 | -16,708 |
| Depreciation Amortization | 35,907 | 13,052 | 16 | 19 | 93 |
| Income taxes - deferred | 1,066 | -3,952 | 0 | 0 | N/A |
| Accounts receivable | 4,614 | -7,694 | -337 | -3,956 | -321 |
| Other Working Capital | 12,861 | -2,192 | 13,736 | -18,530 | 11,769 |
| Other Operating Activity | 41,971 | 20,033 | 7,579 | 3,158 | 4,289 |
| Operating Cash Flow | $-28,786 | $-83,731 | $-16,789 | $366 | $-879 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,299 | -4,166 | -240 | -7 | -2 |
| Net Acquisitions | N/A | -217,887 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 18,838 |
| Other Investing Activity | -215 | -715 | 2,479 | 0 | 0 |
| Investing Cash Flow | $-1,514 | $-222,768 | $2,239 | $-7 | $18,836 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 275,000 | 0 | 0 | N/A |
| Debt Repayment | N/A | -4,700 | N/A | N/A | N/A |
| Common Stock Issued | 108 | 77,658 | 1,735 | 7,589 | 662 |
| Dividend Paid | N/A | N/A | N/A | N/A | -53,686 |
| Other Financing Activity | -6,341 | -1,695 | -2,951 | -194 | -523 |
| Financing Cash Flow | $-6,233 | $346,263 | $-1,216 | $7,395 | $-53,546 |
| Exchange Rate Effect | 482 | 363 | 0 | 0 | N/A |
| Beginning Cash Position | 64,943 | 24,816 | 40,582 | 32,828 | 68,416 |
| End Cash Position | 28,892 | 64,943 | 24,816 | 40,582 | 32,828 |
| Net Cash Flow | $-36,051 | $40,127 | $-15,766 | $7,754 | $-35,589 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,786 | -83,731 | -16,789 | 366 | -879 |
| Capital Expenditure | -1,822 | -4,166 | -240 | -7 | -2 |
| Free Cash Flow | -30,608 | -87,897 | -17,029 | 359 | -881 |